The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today ...
Dr. Reddy’s Laboratories announced the launch of Sumatriptan Injection Autoinjector System for Subcutaneous Use, the generic version of GlaxoSmithKline‘s Imitrex STATdose Pen. Sumatriptan is a ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use, a ...
Dr Reddy’s Laboratories announced on today that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL, for subcutaneous use in the US market on February 25. It is a therapeutic ...
What is sumatriptan used for? Sumatriptan is commonly used for the treatment of migraine with or without aura. An aura may occur before or during a migraine attack, and can include sensory problems ...
The US Food and Drug Administration (FDA) has approved Antares Pharma, Inc's Abbreviated New Drug Application (ANDA) for 4 mg/0.5 ml and 6 mg/0.5 ml Sumatriptan injection USP in adults for the acute ...
EWING, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”), a pharmaceutical technology company, announced the first commercialization of the ...
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated February 25, 2014, titled "Dr Reddy's annouces the Lanch of Sumatriptan Injection USP, Autoinjector System" Dr Reddys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback